A multicentre trial of pentaerythritol tetranitrate (sustained action) 8o mg. b.i.d. in the 3 months after an acute myocardial infarction is described. Included in the trial were 346 patients, and at 6 months, the mortality rates in the treated and control group were almost identical at 23 per cent.
Mortality following acute myocardial infarctions remains high. Hyperbaric oxygen (Cameron et al., 1965) , glucose insulin and potassium (Paulley et al., I967; Medical Research Council, I968) , and propranolol (Snow, I965; Balcon et Estes and Smith, 1966) . Lumb, Singletary, and Hardy (I962) and Lumb and Hardy (I963) have described the value of pentaerythritol tetranitrate in the establishment of collateral circulation after occlusion of the coronary artery in the pig. In the human, sustained action pentaerythritol tetranitrate provides a dosage of 8o mg. (20 mg. immediately, the remainder over I2 hours), and is administered twice daily. The sustained action form of presentation will be abbreviated to PETN in this paper. It has been used as an adjunct therapy in a controlled trial by Oscharoff (I964) 
Patients and methods
The present paper describes a multicentre controlled trial of PETN as an addition to the usual therapy in each co-operating hospital.
Ten clinicians in eight centres took part, contributing in all 346 patients with definite acute myocardial infarction. Diagnosis The fundamental diagnostic question which the physician asked himself was, 'Is this a patient whom I would willingly expose to PETN or to placebo, along with the usual range of analgesics, sedatives, anticoagulants, and oxygen, according to my current practice?'
The essential feature was a fresh myocardial infarction. For inclusion in the trial, treatment with PETN or Dummy must have started within 48 hours of the infarct. In 74 per cent of the cases included it had started within 24 hours, but an additional 9I cases were included where a further day had passed before the patient had been admitted and treatment had begun. In 9 cases included, the exact time of the infarct was not known, but it was under 48 hours.
With this early treatment, the diagnosis could not be confirmed immediately, and a number of cases originally admitted to the trial were withdrawn because the diagnosis of an infarct could not be confirmed on serial electrocardiograms. A total of 346 cases with infarctions is included in this analysis, and a further I26 cases were withdrawn, mainly because the diagnosis was not confirmed. One case was withdrawn on account of severe side effects, a patient who had previously reacted against three other cardiovascular drugs acting on the vascular system. No restriction was made on the history of previous infarction, angina, or diabetes, and the frequency Pentaerythritol tetranitrate (sustained action) in acute myocardial infarction 17 Within the 6-month period, 9-4 per cent of PETN cases and 5 5 per cent of Dummy cases had a further infarct, a non-significant difference. The time distribution to a further infarct was also similar.
At the 6-month re-examination, every surviving patient was assessed by the clinician. Factors relating to mortality within six months Since the PETN or Dummy treatment did not affect the over-all mortality of these patients, the two treatment groups can be combined to provide a larger sample, which can be examined for major factors related to mortality.
Mortality was closely related to age at onset, but there was no evidence of a sex difference in mortality, when age was taken into consideration. For each sex, death occurred within 6 months for about io per cent of the under 60's, 25 per cent of the 6o-69's, and nearly 5o per cent of the patients aged 70 or over. These results are fairly similar to those achieved in an intensive care unit (Lawrie et al., i967) , but as our patients were admitted on average longer after the infarction, strict comparison is not possible. For the same reason, we cannot claim that our mortality rate in hospital was better than that of ig per cent at another intensive care unit (Thomas, Jewitt, and Shillingford, I968) .
A pulse rate of over 95 beats a minute is associated with a mortality of nearly 5o per cent; lower pulse rates have IS per cent mortality.
First infarctions have a better prognosis (mortality of 20%) than subsequent infarctions (mortality of 33%).
No significant mortality associations were found with the hospital centre in the trial, with the time between infarction and treat- 
